The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine.
Nawrocki ST, Han Y, Visconte V, Przychodzen B, Espitia CM, Phillips J, Anwer F, Advani A, Carraway HE, Kelly KR, Sekeres MA, Maciejewski JP, Carew JS.
Nawrocki ST, et al.
Leukemia. 2019 Dec;33(12):2971-2974. doi: 10.1038/s41375-019-0529-2. Epub 2019 Jul 29.
Leukemia. 2019.
PMID: 31358855
Free PMC article.
No abstract available.